Share price: 104.00p

Director/PDMR Shareholding

30th September 2013

 

Cello Group plc (“Cello” or the “Company”)

Director’s dealing

The Company has been notified that on 26 September 2013 Mark Bentley, the Group Finance Director of the Company, exercised an option granted under the Cello Group plc Approved Share Option Plan 2009. 72,000 ordinary shares of 10 pence each in the Company (“Ordinary Shares”) were purchased at an exercise price of 31.5p. Mr Bentley has retained all 72,000 shares.

Mr Bentley also notified the Company that on 26 September 2013 he exercised an option under the Cello Group plc Performance Share Plan 2010. This option allows for the purchase of 214,000 Ordinary Shares at an exercise price of 10p. In order to settle exercise costs and tax liabilities on this option, Mr Bentley further notified the Company that he sold 130,000 Ordinary Shares on 26 September 2013 at a price per share of 65.25p.

Both options were the subject of three year Total Shareholder Return performance conditions measured against a basket of relevant peer group companies. These performance conditions were met in full over that period.

Following the above exercises and sale, Mr Bentley has increased his total beneficial holding by 156,000 Ordinary Shares to 212,276 Ordinary Shares, representing 0.26 per cent. of the current issued share capital of the Company. Mr Bentley remains interested in 588,266 options over Ordinary Shares.

27 September 2013

Enquiries:

Cello Group                                020 7812 8460
Mark Scott, Chief Executive

Cenkos Securities                      020 7397 8900
Bobbie Hilliam

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150